🇺🇸 FDA
Patent

US 10039741

Use of delta tocopherol for the treatment of lysosomal storage disorders

granted A61KA61K31/355A61K31/36

Quick answer

US patent 10039741 (Use of delta tocopherol for the treatment of lysosomal storage disorders) held by The United States of America as Represented by the Secretary of the Department of Health and Human Services expires Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as Represented by the Secretary of the Department of Health and Human Services
Grant date
Tue Aug 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 02 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/355, A61K31/36, A61K31/496, A61K31/724